AI-Powered Research

Willingness to participate in the study
Acceptable visual, auditory and alertness to participate in study
Ability to understand and speak Persian
Having online communication facilities such as internet and one of the smart devices such as laptop, tablet or smartphone.
Ability to use online technology or caregiver to access it during quarantine.
Patients who have been diagnosed with covid 19 and have a lung lesion based on the results of a CXR or CT scan with the approval of an infectious disease specialist
Discharge after treatment
Observance of social isolation
Having a cardiac echo at the time of admission that indicates heart health

Exclusion Criteria

Having deformity in the chest
mental disorder
Any severe illness that impairs the movement of patients such as severe heart disease, severe musculoskeletal pain, vascular aneurysms, severe neurological diseases
Pregnancy
vestibular disorders

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pulmonary function. Timepoint: At the beginning of the study (before the intervention) and at the end of the second week and at the end of the fourth week after the intervention. Method of measurement: By examining the six-minute walk test and measuring the maximum inspiratory pressure (MIP) and the percentage of blood oxygen saturation (SPO2).;Quality of life score in SF-36 questionnaire. Timepoint: At the beginning of the study (before the intervention) and at the end of the second week and at the end of the fourth week after the intervention. Method of measurement: SF-36 questionnaire.

Secondary Outcome Measures

Name	Time	Method
Six-minute walking test (6mwt). Timepoint: At the beginning of the study (before the intervention) and at the end of the second week and at the end of the fourth week after the intervention. Method of measurement: The patient walks a 30-meter flat path in six minutes and the distance is measured.;Maximum inspiratory pressure (MIP). Timepoint: At the beginning of the study (before the intervention) and at the end of the second week and at the end of the fourth week after the intervention. Method of measurement: En IMT K1 POWER BREATH device.;Peripheral capillary oxygen saturation. Timepoint: At the beginning of the study (before the intervention) and at the end of the second week and at the end of the fourth week after the intervention. Method of measurement: Pulse Oximeter.;Fatigue and dyspnea score. Timepoint: At the beginning of the study (before the intervention) and at the end of the second week and at the end of the fourth week after the intervention. Method of measurement: Borg scale 6-20.